Zhejiang Medicine Co., Ltd. (SHA: 600216)
China
· Delayed Price · Currency is CNY 14.52
-0.18 (-1.22%)
Sep 6, 2024, 3:00 PM CST
Zhejiang Medicine Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 13,864 | 10,281 | 11,203 | 16,368 | 13,033 | 12,793 | Upgrade
|
| Market Cap Growth | -0.09% | -8.23% | -31.56% | 25.59% | 1.87% | 52.82% | Upgrade
|
| Enterprise Value | 13,138 | 9,752 | 10,751 | 15,886 | 12,611 | 12,289 | Upgrade
|
| Last Close Price | 14.52 | 10.59 | 11.36 | 16.22 | 12.73 | 11.89 | Upgrade
|
| PE Ratio | 29.41 | 23.67 | 20.28 | 14.88 | 16.97 | 33.03 | Upgrade
|
| PS Ratio | 1.68 | 1.32 | 1.38 | 1.79 | 1.78 | 1.82 | Upgrade
|
| PB Ratio | 1.33 | 1.03 | 1.15 | 1.78 | 1.62 | 1.55 | Upgrade
|
| P/FCF Ratio | -159.90 | -63.24 | -24.60 | 83.06 | 18.07 | -101.23 | Upgrade
|
| P/OCF Ratio | 17.73 | 16.21 | 21.52 | 14.40 | 10.37 | 28.60 | Upgrade
|
| EV/Sales Ratio | 1.59 | 1.25 | 1.32 | 1.74 | 1.72 | 1.74 | Upgrade
|
| EV/EBITDA Ratio | 13.98 | 15.23 | 9.18 | 9.09 | 9.84 | 16.25 | Upgrade
|
| EV/EBIT Ratio | 57.11 | -537.30 | 21.95 | 13.69 | 16.22 | 45.77 | Upgrade
|
| EV/FCF Ratio | -200.39 | -59.99 | -23.61 | 80.62 | 17.48 | -97.24 | Upgrade
|
| Debt / Equity Ratio | 0.08 | 0.08 | 0.09 | 0.05 | 0.12 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 0.85 | 1.30 | 0.71 | 0.27 | 0.74 | 0.86 | Upgrade
|
| Debt / FCF Ratio | -12.22 | -5.12 | -1.83 | 2.42 | 1.32 | -5.14 | Upgrade
|
| Asset Turnover | 0.65 | 0.62 | 0.65 | 0.79 | 0.70 | 0.69 | Upgrade
|
| Inventory Turnover | 2.81 | 2.69 | 2.81 | 3.30 | 3.03 | 3.25 | Upgrade
|
| Quick Ratio | 1.68 | 1.39 | 1.40 | 1.30 | 1.82 | 1.69 | Upgrade
|
| Current Ratio | 2.66 | 2.26 | 2.29 | 2.00 | 2.66 | 2.46 | Upgrade
|
| Return on Equity (ROE) | 3.40% | 2.81% | 3.84% | 10.28% | 8.10% | 3.57% | Upgrade
|
| Return on Assets (ROA) | 1.12% | -0.09% | 2.45% | 6.30% | 4.66% | 1.64% | Upgrade
|
| Return on Capital (ROIC) | 1.31% | -0.11% | 3.03% | 7.78% | 5.43% | 1.92% | Upgrade
|
| Earnings Yield | 3.40% | 4.18% | 4.82% | 6.39% | 5.50% | 2.68% | Upgrade
|
| FCF Yield | -0.47% | -1.58% | -4.07% | 1.20% | 5.54% | -0.99% | Upgrade
|
| Dividend Yield | 1.03% | 1.42% | 1.50% | 2.04% | 1.81% | 8.41% | Upgrade
|
| Payout Ratio | 40.43% | 44.67% | 65.07% | 24.88% | 140.26% | 49.01% | Upgrade
|
| Buyback Yield / Dilution | 1.09% | 0.31% | -0.47% | -0.26% | -0.46% | 0.75% | Upgrade
|
| Total Shareholder Return | 2.12% | 1.73% | 1.03% | 1.78% | 1.35% | 9.16% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.